Cargando…

Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases

BACKGROUND: Chronic lymphocytic leukemia is a malignancy with good prognosis. However, the incidence of secondary tumors increases every year after the diagnosis of chronic lymphotcytic leukemia. One of the induced secondary tumors is prostate cancer. For high-risk prostate cancer in particular, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yinjie, Wang, Yanqing, Qian, Zhiyu, Pan, Jiahua, Liu, Qiang, Dong, Baijun, Xue, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617590/ https://www.ncbi.nlm.nih.gov/pubmed/31288785 http://dx.doi.org/10.1186/s12885-019-5876-x

Ejemplares similares

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
por: Wang, Yanqing, et al.
Publicado: (2016)

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits
por: Zhu, Yinjie, et al.
Publicado: (2023)

Urachal Carcinoma: Are Lymphadenectomy and Umbilectomy Necessary?
por: Jia, Zhuo, et al.
Publicado: (2020)

Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations
por: Chi, Chenfei, et al.
Publicado: (2022)

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer
por: Fei, Xiaochen, et al.
Publicado: (2023)

The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)
por: Liu, Jiazhou, et al.
Publicado: (2022)

Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer
por: Wang, Yanqing, et al.
Publicado: (2017)

Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S
por: Pan, Jiahua, et al.
Publicado: (2019)

The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
por: Fei, Xiaochen, et al.
Publicado: (2021)

PRKAR2B‐HIF‐1α loop promotes aerobic glycolysis and tumour growth in prostate cancer
por: Xia, Lei, et al.
Publicado: (2020)

AB045. Extended lymphadenectomy versus non-extended lymphadenectomy in radical cystectomy for bladder cancer: a meta-analysis
por: Yan, Binyuan
Publicado: (2016)

D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
por: Shrikhande, Shailesh V, et al.
Publicado: (2013)

Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone
por: Fan, Liancheng, et al.
Publicado: (2017)

Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?
por: Li, Jian, et al.
Publicado: (2020)

Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
por: Dong, Baijun, et al.
Publicado: (2020)

AB140. Efficacy of radical prostatectomy combined with neoadjuvant chemotherapy in the treatment of locally advanced prostate cancer: preliminary experiences from a single center
por: Xue, Wei, et al.
Publicado: (2016)

Extended robotic salvage lymphadenectomy in patients with ‘node-only’ prostate cancer recurrence: initial experience
por: Kolontarev, Konstantin, et al.
Publicado: (2018)

Effectiveness of extended pelvic lymphadenectomy in the survival of prostate cancer: a systematic review and meta-analysis
por: García-Perdomo, Herney Andrés, et al.
Publicado: (2018)

Extended lymphadenectomy for locally advanced and recurrent rectal cancer
por: Georgiou, Panagiotis A., et al.
Publicado: (2017)

THE ROLE OF LYMPHADENECTOMY IN PROSTATE CANCER PATIENTS
por: Markić, Dean, et al.
Publicado: (2019)

m(6)A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1
por: Xia, Lei, et al.
Publicado: (2022)

Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors
por: Fan, Liancheng, et al.
Publicado: (2018)

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer
por: Du, Xinxing, et al.
Publicado: (2023)

Merkel cell carcinoma: extended lymphadenectomy and reconstruction with biosynthetic prosthesis
por: Coppola Bottazzi, Enrico, et al.
Publicado: (2018)

Is there an oncological benefit to extended lymphadenectomy for muscle-invasive bladder cancer?
por: Clinton, Timothy N., et al.
Publicado: (2020)

Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
por: Rasmusson, Elisabeth, et al.
Publicado: (2013)

Engineering the MoS(2)/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens
por: Xie, Shaowei, et al.
Publicado: (2023)

Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages
por: Lyu, Shao-Cheng, et al.
Publicado: (2022)

PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer
por: Sha, Jianjun, et al.
Publicado: (2016)

Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy
por: Xu, Fan, et al.
Publicado: (2016)

Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer
por: Xu, Xinbao, et al.
Publicado: (2013)

Transcervical extended mediastinal lymphadenectomy for mediastinal restaging after induction therapy
por: Gwóźdź, Paweł, et al.
Publicado: (2019)

Extended lymphadenectomy in locally advanced rectal cancers: a systematic review
por: Mahendran, Balaji, et al.
Publicado: (2022)

Extended Lymphadenectomy for Proximal Transverse Colon Cancer: Is There a Place for Standardization?
por: Popescu, Răzvan Cătălin, et al.
Publicado: (2022)

QS5: Extended Venous Thromboembolism Prophylaxis May Not Be Necessary For DIEP Flap Breast Reconstruction
por: Huang, Hao, et al.
Publicado: (2021)

The Role of Pelvic Lymphadenectomy in the Management of Prostate and Bladder Cancer
por: Woods, Michael E., et al.
Publicado: (2007)

Diagnostic Value of Radio-Guided Sentinel Node Detection in Patients with Prostate Cancer Undergoing Radical Prostatectomy with Modified-Extended Lymphadenectomy
por: Małkiewicz, Bartosz, et al.
Publicado: (2022)

Why an extended evolutionary synthesis is necessary
por: Müller, Gerd B.
Publicado: (2017)

Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL
por: Chen, Na, et al.
Publicado: (2017)

Regional lymphadenectomy vs. extended lymphadenectomy for hilar cholangiocarcinoma (Relay-HC trial): study protocol for a prospective, multicenter, randomized controlled trial
por: He, Min, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dnnh78jd9f35v9rs24ekq3pa82